Advertisement
Screener

Johnson & Johnson (JNJ) ROI

JOHNSON & JOHNSON ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • JOHNSON & JOHNSON roi for the quarter ending 2026-06-28 was 15.70%, a 10.47% decline year-over-year.
  • JOHNSON & JOHNSON roi for the quarter ending 2026-03-29 was 15.45%, a 7.65% decline year-over-year.
  • JOHNSON & JOHNSON roi for the quarter ending 2025-12-28 was 20.70%, a 59.13% increase year-over-year.
  • JOHNSON & JOHNSON roi for the quarter ending 2025-09-28 was 20.08%, a 44.85% increase year-over-year.
  • JOHNSON & JOHNSON roi for fiscal 2025 was 20.70%, a 59.13% increase from fiscal 2024.
  • JOHNSON & JOHNSON roi for fiscal 2024 was 13.01%, a 63.69% decline from fiscal 2023.
  • JOHNSON & JOHNSON roi for fiscal 2023 was 35.83%, a 132.57% increase from fiscal 2023.
  • JOHNSON & JOHNSON roi for fiscal 2023 was 15.41%, a 20.47% decline from fiscal 2022.
Available history
2011-01-02 to 2026-06-28
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2026-06-2815.70%$21.04B$5.53B$134.01B
2026-03-2915.45%$21.04B$5.24B$136.17B
2025-12-2820.70%$26.8B$5.12B$129.48B
2025-09-2820.08%$25.12B$5.15B$125.07B
2025-06-2917.53%$22.66B$5.54B$129.23B
2025-03-3016.73%$21.81B$11.00B$130.36B
2024-12-2913.01%$14.07B$3.43B$108.12B
2024-09-2913.86%$14.68B$2.69B$105.91B
2024-06-3033.64%$38.02B$4.69B$113.03B
2024-03-3137.12%$38.48B$3.25B$103.65B
2023-12-3135.83%$35.15B$4.05B$98.11B
2023-10-0134.23%$34.62B$26.03B$101.15B
2023-07-0210.70%$13.05B$5.14B$122.01B
2023-04-0210.28%$12.72B-$68.00M$123.78B
2023-01-0115.41%$17.94B$3.52B$116.45B
2022-10-0217.97%$19.16B$4.46B$106.63B
2022-07-0316.86%$18.37B$4.81B$108.95B
2022-04-0318.39%$19.83B$5.15B$107.86B
2022-01-0219.37%$20.88B$4.74B$107.77B
2021-10-0317.16%$17.88B$3.67B$104.2B
2021-07-0417.24%$17.77B$6.28B$103.06B
2021-04-0415.20%$15.12B$6.20B$99.45B
2021-01-0314.93%$14.71B$1.74B$98.54B
2020-09-2716.62%$16.99B$3.55B$102.23B
2020-06-2816.26%$15.19B$3.63B$93.37B
2020-03-2919.31%$17.17B$5.80B$88.88B
2019-12-2917.34%$15.12B$4.01B$87.17B
2019-09-2916.19%$14.15B$1.75B$87.43B
2019-06-3018.11%$16.33B$5.61B$90.2B
2019-03-3116.62%$14.68B$3.75B$88.32B
2018-12-3016.95%$15.3B$3.04B$90.23B
2018-09-301.61%$1.54B$3.93B$95.88B
2018-07-011.44%$1.37B$3.95B$94.97B
2018-04-011.30%$1.25B$4.37B$95.79B
2017-12-311.37%$1.3B-$10.71B$94.74B
2017-10-0114.50%$15.83B$3.76B$109.15B
2017-07-0215.34%$16.34B$3.83B$106.49B
2017-04-0216.07%$16.51B$4.42B$102.71B
2017-01-0116.96%$16.54B$3.81B$97.54B
2016-10-0215.98%$15.94B$4.27B$99.76B
2016-07-0315.22%$15.03B$4.00B$98.72B
2016-04-0316.19%$15.55B$4.46B$96B
2016-01-0316.93%$15.41B$3.21B$91.01B
2015-09-2716.12%$14.72B$3.36B$91.3B
2015-06-2817.81%$16.11B$4.52B$90.44B
2015-03-2918.32%$15.92B$4.32B$86.86B
2014-12-2818.44%$16.32B$2.52B$88.51B
2014-09-2818.86%$17.32B$4.75B$91.86B
2014-06-2916.34%$15.55B$4.33B$95.17B
2014-03-3016.04%$15.06B$4.73B$93.87B
2013-12-2915.00%$13.83B$3.52B$92.23B
2013-09-2915.17%$12.88B$2.98B$84.91B
2013-06-3015.20%$12.87B$3.83B$84.65B
2013-03-3112.62%$10.44B$3.50B$82.75B
2012-12-3013.40%$10.85B$2.57B$80.99B
2012-09-3010.55%$8.5B$2.97B$80.61B
2012-07-0111.20%$8.74B$1.41B$78B

Annual ROI

DateROINet income 12 monthDebt plus equity
2025-12-2820.70%$26.8B$129.48B
2024-12-2913.01%$14.07B$108.12B
2023-12-3135.83%$35.15B$98.11B
2023-01-0115.41%$17.94B$116.45B
2022-01-0219.37%$20.88B$107.77B
2021-01-0314.93%$14.71B$98.54B
2019-12-2917.34%$15.12B$87.17B
2018-12-3016.95%$15.3B$90.23B
2017-12-311.37%$1.3B$94.74B
2017-01-0116.96%$16.54B$97.54B
2016-01-0316.93%$15.41B$91.01B
2014-12-2818.44%$16.32B$88.51B
2013-12-2915.00%$13.83B$92.23B
2012-12-3013.40%$10.85B$80.99B
2012-01-0112.61%$9.67B$76.71B
2011-01-0218.18%$13.33B$73.35B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38